Volume 45, Issue 1 , Pages 45-52, January 2003
Igm recognition of recombinant Toxoplasma gondii antigens by sera of acutely or latently infected humans
Abstract
Clinical non-relevant (CNR) IgM specific for Toxoplasma gondii is responsible for false-positive results in commercially available IgM assays. Using IgM immunoblotting, it is possible to distinguish between IgM in sera of acutely infected (AI) patients and CNR IgM. Especially the combination of staining of a 55 and 30 kD antigen in T.gondii lysate proved useful in this respect. The 55 kD antigen was identified as Rop1, while the 30 kD antigen was confirmed to be Sag1. However, the use of recombinant antigens instead of lysates for diagnostic assays would improve reproducibility. IgM recognized recombinant Rop1, but most CNR sera also had low anti-Rop1 titers. Although purified native Sag1 separated AI and CNR sera very well on immunoblot, IgM did not recognize recombinant Sag1 at all. Clearly, it is difficult to produce a recombinant Sag1 that can be recognized by IgM. Recombinant Rop1 might be suitable as one of the recombinant antigens in an IgM immunoblot assay, but has to be combined with at least one other immunogenic antigen.
Keywords: Human, Toxoplasma, IgM, Recombinant antigens, Sag1, Rop1, Gra2, Immunoblotting
To access this article, please choose from the options below
PII: S0732-8893(02)00476-5
doi:10.1016/S0732-8893(02)00476-5
© 2003 Elsevier Science Inc. All rights reserved.
Volume 45, Issue 1 , Pages 45-52, January 2003
